ISPOR Asia-Pacific Conference in Beijing, China to Focus on Health Care Reform, Big Data, and Patients in Asia

General Press Releases Tuesday August 19, 2014 08:05

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR), in conjunction with the ISPOR Asia Consortium, and the China Pharmaceutical Association Pharmacoeconomics Society has organized the ISPOR 6th Asia-Pacific Conference, which will take place September 6-9, 2014 at the Beijing International Convention Center in Beijing, China. Presentations from this conference will focus on a comparison of China and South Korea's health care reform with Obamacare, incorporating the patient's voice into health care decision making, health technology assessment (HTA) in Asia, using "Big Data" in health economics and outcomes research (HEOR), and the development of electronic health records in Asia. Perspectives from noted international key opinion leaders and decision makers will be featured.

In the opening session, the State Leader, Vice Chairman of the 11th National Peoples' Congress of China and Honorary Conference Chair, Professor Guowei Sang, will deliver a keynote speech, "Pharmaceutical Policy, Research, and Development in China."   Since health care reform has brought significant changes to the health care system and infrastructure in China and has created new opportunities for different stakeholders, the question has become: "Who are the true winners and who are the losers? Is the reform successful in achieving its goal of equality and quality of care for all patients?" Therefore, during the session, "China Health Care Reform: Who Gains and Who Loses?" experiences and lessons learned with South Korea's successful health care reform, the USA's Affordable Health Care Act (Obamacare), as well as health care reform in China will be examined. The trend of China heath care reform for the next decade will also be explored.

Health care is for the patient, but the patient's voice is often lost in the debate among different stakeholders. This is particularly true in health care delivery and health care policymaking in Asia where health care providers, payers, and producers usually dominate the discussion. Patient groups are established to amplify the patient's voice not only at the health care delivery level, but also at the formulary and reimbursement level. As a result, speakers in the session, "Hearing the Patient's Voice in Health Care Decision Making in Asia," will discuss the challenges and opportunities for incorporating patient perspectives into health care decisions in Asia through the efforts of patient organizations, and how the patient's voice is often lost in the debate.

Lastly, health care data is essential for evidence-based decision making, but with the current data deficit in Asia, providers, researchers, and policymakers are often limited in how they can better apply the knowledge and make the right decision for the patient. Electronic health records (EHRs) are an important resource for capturing patients' up-to-date health information accurately and completely for smarter health care. In the session, "Electronic Health Records for Informed Health Care in Asia-Pacific: Learning from Each Other," attendees will learn about the issues that health care systems in Asia are facing in developing electronic health record (EHR) software, collecting and using data, as well as privacy concerns. In addition to an examination of how EHRs can be adopted in Asia, international experience and lessons learned will be shared.

Additional highlighted sessions include:
-- How to Construct Reimbursement Submissions in the Absence of Head-to-Head
Clinical Data
-- Improving the Validity of Health Economic Research Using Big Data and
Real World Evidence
-- Managing High-Cost, Innovative Pharmaceuticals in Asia: Is Something Lost
When Translating Theory into Practice?
-- Updating Reimbursement Guidelines in Asia-Pacific: Who's Doing What?
-- Value of Real World Non-Interventional Research In Oncology: Global and
Asia Experiences and Challenges
-- The Potential for HTA in Health Care Development Assistance Programs in

The ISPOR 6th Asia-Pacific Conference also has a new extended program that includes one and a half days of pre-meeting educational courses and two and a half days of scientific presentations. Over 1,200 researchers, decision makers, and health technology assessors from over 40 countries are expected to attend.

To register for the ISPOR 6th Asia-Pacific Conference, please visit:
Keep up with meeting events by following @ISPORorg on Twitter: #ISPORBeijing.

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational, and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health. To learn more about the educational and scientific resources ISPOR offers, or to become a member, please visit:

CONTACT: Media Contact:
Danielle Mroz, MA, Director, Communications, ISPOR

Latest Press Release

National Geographic Society, Campaign for Nature representatives join nations in Canada to push an ambitious global agenda for nature

Growing coalition of scientists, government leaders, NGOs, businesses, and philanthropists push nations to protect at least 30 percent of the planet by 2030 With only 18 months left before world leaders meet in China to finalize an agreement to address...

International Day of Football and Friendship Celebrated in Schools Around the World

April 25 is the International Day of Football and Friendship. This year, it was celebrated in schools and sports academies of more than 50 countries of Europe, Asia, Africa, North and South America. The activities involved meetings, training, and...

Propose a Toast! With Mouth-Watering Thai Tea Toast at Cafe Kantary

From 1 May until 30 June 2019, it's time for Thai Tea Toast! Enjoy Thai-style crunchy-creamy Thai Tea Toast any time of the day, with a buttery slice of crispy toast drizzled with Thai tea sauce and topped with Thai tea ice cream. Come and try a cream...

MRTA BEM Announce that the First New Train for the MRT Blue Line Extension Has Arrived in Thailand

The Mass Rapid Transit Authority of Thailand (MRTA) and the Bangkok Expressway and Metro Public Company Limited (BEM) announce that the first new train for the MRT Blue Line has arrived at Laem Chabang Port. BEM, as the concessionaire to operate the MRT...

Getaround Becomes Global Carsharing Leader With $300 Million Acquisition Of European Platform Drivy

- Combines strengths of both companies to form a leading global transportation and mobility company spanning North America and Europe - Broadens Getaround's presence into 170 European cities - Accelerates Getaround's mission to empower people to...

Related Topics